Search Results - "Eusebio, R.A"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Effect of renal function on risedronate pharmacokinetics after a single oral dose by Mitchell, D. Y., St. Peter, J. V., Eusebio, R.A., Pallone, K. A., Kelly, S. C., Russell, D. A., Nesbitt, J. D., Thompson, G. A., Powell, J. H.

    Published in British journal of clinical pharmacology (01-03-2000)
    “…Aims  To determine the relationship between risedronate pharmacokinetics and renal function. Methods  Risedronate was administered to adult men and women…”
    Get full text
    Journal Article
  2. 2

    Improvement of pagetic bone lesions with risedronate treatment: a radiologic study by Brown, J.P, Chines, A.A, Myers, W.R, Eusebio, R.A, Ritter-Hrncirik, C, Hayes, C.W

    Published in Bone (New York, N.Y.) (01-03-2000)
    “…Risedronate is a potent pyridinyl bisphosphonate in clinical development for treatment and prevention of osteoporosis, and has been recently approved for…”
    Get full text
    Journal Article
  3. 3

    Paget’s Disease of Bone: Reduction of Disease Activity With Oral Risedronate by Hosking, D.J, Eusebio, R.A, Chines, A.A

    Published in Bone (New York, N.Y.) (1998)
    “…Risedronate monosodium [1-hydroxy-2-(3-pyridinyl)ethylidene bisphosphonic acid monosodium salt] is a pyridinyl bisphosphonate drug under development as a…”
    Get full text
    Journal Article
  4. 4
  5. 5